FDA Inspection Readiness

FDA Inspection Intelligence Built
by Former FDA Investigators

Prepare for FDA inspections, respond to Form FDA 483 observations and Warning Letters, and strengthen inspection readiness with experienced former FDA investigators.

Facing an active inspection or response deadline? Call (888) 781-1822.

Step Inside a Regulated Facility

Request Confidential FDA Help Explore Inspection Services

Start With the FDA Problem in Front of You

Choose the support that fits your situation today

Active inspection FDA is currently inspecting us Get fast help with inspection-room conduct, document requests, daily debriefs, and next-step planning. Get Urgent Inspection Support 483 or Warning Letter We received a Form FDA 483 Request help with observation review, root cause work, CAPA planning, response drafting, and evidence packages. Request Confidential Response Help Inspection readiness We need to prepare before FDA arrives Plan a readiness review for records, staff roles, quality systems, inspection flow, and likely investigator questions. Plan an Inspection Readiness Review

Former FDA Investigators   ·   Inspection Readiness   ·   FDA Response Support

Former FDA investigators consulting with a client team

Why Choose Us

Former FDA Investigators.
Real Inspection Experience.

FDAInspections.com is led by former FDA investigators with direct agency experience helping regulated companies prepare for inspections, respond to observations, and strengthen inspection readiness.

  • Understand how FDA investigators approach inspections
  • Anticipate document and record requests
  • Identify issues likely to attract investigator attention
  • Strengthen responses, CAPAs, and remediation strategies
Request a Confidential Consultation

What We Do

FDA Inspection Consulting Services

Every engagement is scoped to your facility, timeline, and FDA situation. Tell us what you are facing, and we will recommend the appropriate level of support.

Request a Confidential Consultation

Industries Served

Inspection Support Across
FDA-Regulated Environments

See the facility types, records, and inspection risks our former FDA investigators help teams prepare for.

Pharmaceutical Manufacturing From dispensing to packaging, every cGMP control under one roof. Explore Industry Biologics Manufacturing Upstream, downstream, and aseptic fill, with biologics pressure points in view. Explore Industry Medical Device Manufacturing Design controls, CAPA, and complaint handling under 21 CFR 820 / QMSR. Explore Industry Food Manufacturing FSMA, allergen control, and environmental pathogen monitoring. Explore Industry Cosmetics Manufacturing MoCRA compliance, adverse event reporting, and facility registration. Explore Industry Compounding Pharmacy USP <797>, <800>, and FDA 503B outsourcing facility expectations. Explore Industry QC Analytical Laboratory HPLC, dissolution, stability, LIMS, and the data integrity that ties them together. Explore Industry Microbiology Laboratory Sterility, endotoxin, EM, and contamination-control records under inspection pressure. Explore Industry

Immersive Experience

Step Inside a Regulated Facility

Walk through an FDA-regulated environment the way an investigator sees it, reviewing records, rooms, systems, and the questions that can shape an inspection.

Enter the Immersive Walkthrough

Enforcement Intelligence

FDA Regulatory
Intelligence

Use FDA enforcement patterns and trend analysis to prepare for the inspection issues regulators keep finding.

FDA Warning Letter Analysis

Search FDA Warning Letter patterns across regulated sectors and identify recurring enforcement themes that can inform inspection planning.

Explore Intelligence

FDA 483 Observation Intelligence

Explore FDA 483 observation trends by category to understand the issues investigators most frequently identify.

Explore Intelligence

Quality System Intelligence

FDA Observations Often Begin With
Quality-System Weaknesses

Inspection findings are rarely isolated events. They often trace back to gaps in:

  • Documentation
  • CAPA Effectiveness
  • Training
  • Data Integrity
  • Validation
  • Management Oversight
Explore FDA Inspection Intelligence

Latest Insights

FDA Inspection Articles and Resources

Common Questions

Frequently Asked Questions

FDA inspection readiness means the facility, records, quality systems, and staff are prepared for FDA review before an investigator arrives.

An FDA Form 483 lists inspection observations. Companies should review each item, identify root causes, prepare corrective actions, and send a written response within the FDA response window.

Companies can prepare through mock inspections, GMP gap reviews, document checks, staff interview practice, CAPA review, and inspection-room planning.

FDA may issue a warning letter when inspection findings, product issues, records, responses, or repeated violations show that a company has not corrected regulatory problems.

A mock FDA inspection can surface weak records, unclear staff answers, and quality system gaps before FDA sees them, giving the team time to correct problems ahead of an actual inspection.

Take Action

Talk With a Former
FDA Investigator

Send us the FDA document, inspection concern, or readiness timeline. We will review your situation and recommend the most appropriate next step.

Request Confidential FDA Help Call (888) 781-1822
FDA Inspection Alerts